Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
China flag China · Delayed Price · Currency is CNY
27.47
+0.28 (1.03%)
Feb 3, 2026, 3:00 PM CST

SHA:600993 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
3,7253,6803,0983,4973,3632,775
Other Revenue
48.548.538.335.1222.5316.54
3,7733,7283,1373,5323,3852,792
Revenue Growth (YoY)
8.36%18.85%-11.20%4.35%21.26%3.19%
Cost of Revenue
1,9841,9971,8292,0382,0191,688
Gross Profit
1,7901,7311,3071,4941,3661,104
Selling, General & Admin
1,0781,051825.21886.06818.05668.73
Research & Development
73.7866.6969.0177.8966.7355.66
Other Operating Expenses
29.0126.2924.3926.1625.0620.91
Operating Expenses
1,1881,153922.541,000912.9754.83
Operating Income
602.3578.43384.73494.16453.38349.08
Interest Expense
-8.54-7.38-16.85-11.69-10.21-6.98
Interest & Investment Income
68.2678.88151.598.9278.8530.4
Currency Exchange Gain (Loss)
-0.06-0.060.050.04-0.21-0.06
Other Non Operating Income (Expenses)
4.770.99-3.78-6.22-4.92-5.08
EBT Excluding Unusual Items
666.74650.87515.65575.22516.89367.36
Gain (Loss) on Sale of Investments
13.66-6.57-0.35-38.0617.63100.55
Gain (Loss) on Sale of Assets
-0.7-0.141.12-0.01-0.57.58
Asset Writedown
0.99-5.25--0.34-0.44-0.42
Other Unusual Items
16.0818.648.2822.3314.5822.62
Pretax Income
696.76657.55524.7559.14548.16497.69
Income Tax Expense
101.37109.2672.8679.7874.1167.05
Earnings From Continuing Operations
595.4548.3451.84479.35474.05430.64
Minority Interest in Earnings
-23.8-20.2-8.59-0.78-9.46-11.58
Net Income
571.6528.09443.25478.57464.59419.06
Net Income to Common
571.6528.09443.25478.57464.59419.06
Net Income Growth
18.50%19.14%-7.38%3.01%10.87%16.42%
Shares Outstanding (Basic)
430429430431430432
Shares Outstanding (Diluted)
430429430431430432
Shares Change (YoY)
-0.23%-0.23%-0.19%0.22%-0.43%0.81%
EPS (Basic)
1.331.231.031.111.080.97
EPS (Diluted)
1.331.231.031.111.080.97
EPS Growth
18.77%19.42%-7.21%2.78%11.34%15.48%
Free Cash Flow
545.93293.76355.7266.84532.07237.58
Free Cash Flow Per Share
1.270.680.830.621.240.55
Dividend Per Share
0.6200.6200.4000.3500.3500.300
Dividend Growth
55.00%55.00%14.29%-16.67%15.38%
Gross Margin
47.44%46.43%41.68%42.30%40.36%39.54%
Operating Margin
15.96%15.52%12.26%13.99%13.39%12.50%
Profit Margin
15.15%14.17%14.13%13.55%13.73%15.01%
Free Cash Flow Margin
14.47%7.88%11.34%7.55%15.72%8.51%
EBITDA
641.53622.05434.2541.14495.12384.34
EBITDA Margin
17.00%16.69%13.84%15.32%14.63%13.77%
D&A For EBITDA
39.2443.6249.4846.9841.7435.25
EBIT
602.3578.43384.73494.16453.38349.08
EBIT Margin
15.96%15.52%12.26%13.99%13.39%12.50%
Effective Tax Rate
14.55%16.61%13.89%14.27%13.52%13.47%
Revenue as Reported
3,7733,7283,1373,5323,3852,792
Advertising Expenses
-161.6472.5681.2559.9949.06
Source: S&P Global Market Intelligence. Standard template. Financial Sources.